Form 4: Cytokinetics CEO Robert Blum Reports Gift Transaction of Common Stock
SEC Form 4 Filing
Robert Blum, President & CEO of Cytokinetics Inc, reported a gift transaction involving 1,956 shares of common stock on August 19, 2024.
Summary
- On August 19, 2024, Robert I Blum, the President & CEO of Cytokinetics Inc, filed a Form 4.
- The filing reports a transaction where 1,956 shares of Cytokinetics' common stock were gifted.
- Following the transaction, Mr. Blum directly owns 397,456 shares of common stock.
- He also indirectly owns 2,083 shares through The Bridget Blum 2003 Irrevocable Trust and 2,083 shares through The Brittany Blum 2003 Irrevocable Trust.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing regarding a gift transaction, which doesn't inherently indicate positive or negative sentiment.
Industry Context
Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.
Stakeholder Impact
- The gift transaction itself is unlikely to have a significant impact on stakeholders.
Key Dates
| Date | Description |
|---|---|
| 08/19/2024 | Date of the gift transaction and filing of Form 4 |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.